Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Sarcoma 2Neoplasm Metastasis 2Stomach Neoplasms 1Prostatic Neoplasms 1Osteosarcoma 1Colorectal Neoplasms 1Castration-resistant Prostate Cancer 1Bone Neoplasms 1Adenocarcinoma 1

Interventions

regorafenib 1dinutuximab 1Weight-Bearing 1Surveys and Questionnaires 1Standard of Care 1Restraint, Physical 1Range of Motion, Articular 1Quality of Life 1Quality Assurance, Health Care 1Platinum 1Observation 1Metastasectomy 1Masks 1Magnetic Resonance Imaging 1Genetic Testing 1Gemcitabine 1Doxorubicin 1Data Collection 1Cyclophosphamide 1Cisplatin 1Behavioral Sciences 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Bone Neoplasms × Metastasectomy × Clear all
NCT03965234 2026-03-17

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Roswell Park Cancer Institute

Phase 1/2 Recruiting
99 enrolled
GastrointestinalSarcoma

Bone Neoplasms, Sarcoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡